Diabetes, Vol 39, Issue 5 534-540, Copyright © 1990 by American Diabetes Association

ARTICLES

Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients

P Diem, M Abid, JB Redmon, DE Sutherland and RP Robertson
Department of Medicine, University of Minnesota, Minneapolis 55455.

To evaluate the metabolic consequences of pancreas transplantation with systemic venous drainage on beta-cell function, we examined insulin and C-peptide responses to glucose and arginine in type I (insulin-dependent) diabetic pancreas recipients (n = 30), nondiabetic kidney recipients (n = 8), and nondiabetic control subjects (n = 28). Basal insulin levels were 66 +/- 5 pM in control subjects, 204 +/- 18 pM in pancreas recipients (P less than 0.0001 vs. control), and 77 +/- 17 pM in kidney recipients. Acute insulin responses to glucose were 416 +/- 44 pM in control subjects, 763 +/- 91 pM in pancreas recipients (P less than 0.01 vs. control), and 589 +/- 113 pM in kidney recipients (NS vs. control). Basal and stimulated insulin levels in two pancreas recipients with portal venous drainage were normal. Integrated acute C-peptide responses were not statistically different (25.3 +/- 4.3 nM/min in pancreas recipients, 34.2 +/- 5.5 nM/min in kidney recipients, and 23.7 +/- 2.1 nM/min in control subjects). Similar insulin and C-peptide results were obtained with arginine stimulation, and both basal and glucose-stimulated insulin-C-peptide ratios in pancreas recipients were significantly greater than in control subjects. We conclude that recipients of pancreas allografts with systemic venous drainage have elevated basal and stimulated insulin levels and that these alterations are primarily due to alterations of first-pass hepatic insulin clearance, although insulin resistance secondary to immunosuppressive therapy (including prednisone) probably plays a contributing role. To avoid hyperinsulinemia and its possible long-term adverse consequences, transplantation of pancreas allografts into sites with portal rather than systemic venous drainage should be considered.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. J. Meier, I. Hong-McAtee, R. Galasso, J. D. Veldhuis, A. Moran, B. J. Hering, and P. C. Butler Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes, August 1, 2006; 55(8): 2324 - 2332. [Abstract] [Full Text] [PDF]

				M. Stadler, C. Anderwald, T. Karer, A. Tura, T. Kastenbauer, M. Auinger, C. Bieglmayer, O. Wagner, F. Kronenberg, P. Nowotny, et al. Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: A sign of impaired {beta}-cell function? Diabetes Care, May 1, 2006; 29(5): 1031 - 1038. [Abstract] [Full Text] [PDF]

				K. Bouzakri, H. K.R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J. R. Zierath IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients Diabetes, March 1, 2006; 55(3): 785 - 791. [Abstract] [Full Text] [PDF]

				M. Monroy-Cuadros, A. Salazar, S. Yilmaz, and K. McLaughlin Bladder vs enteric drainage in simultaneous pancreas-kidney transplantation Nephrol. Dial. Transplant., February 1, 2006; 21(2): 483 - 487. [Abstract] [Full Text] [PDF]

				J. L. Larsen Pancreas Transplantation: Indications and Consequences Endocr. Rev., December 1, 2004; 25(6): 919 - 946. [Abstract] [Full Text] [PDF]

				R. P. Robertson Consequences on {beta}-Cell Function and Reserve After Long-Term Pancreas Transplantation Diabetes, March 1, 2004; 53(3): 633 - 644. [Abstract] [Full Text] [PDF]

				A. Carpentier, B. W. Patterson, K. D. Uffelman, A. Giacca, M. Vranic, M. S. Cattral, and G. F. Lewis The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism Diabetes, June 1, 2001; 50(6): 1402 - 1413. [Abstract] [Full Text]

				E. Christiansen, L. L. Kjems, A. Volund, A. Tibell, C. Binder, and S. Madsbad Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E716 - E725. [Abstract] [Full Text] [PDF]

				E. Christiansen, A. Tibell, Aa. Volund, J. J. Holst, K. Rasmussen, L. Schaffer, and S. Madsbad Metabolism of Oral Glucose in Pancreas Transplant Recipients with Normal and Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2299 - 2307. [Abstract] [Full Text] [PDF]

				T. Arndt, R. Hackler, T. Muller, T. O. Kleine, and A. M. Gressner Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation Clin. Chem., February 1, 1997; 43(2): 344 - 351. [Abstract] [Full Text] [PDF]